Vnitr Lek 2018, 64(4):437-440 | DOI: 10.36290/vnl.2018.062

Virilization as demonstration of hypertestosteronism by ovarian tumor: case report

Michal Mokáň1, František Nehaj1, Juraj Sokol2,*, Peter Vaňuga3, Marián Mokáň1
1 I. interná klinika JLF UK a UNM, Martin, Slovenská republika
2 Klinika hematológie a transfuziológie, Národné centrum hemostázy a trombózy, JLF UK a UNM, Martin, Slovenská republika
3 Národný endokrinologický a diabetologický ústav, n.o., Ľubochňa, Slovenská republika

Hypertestosteronism as part of hyperandrogenic states in women is generally defined as abundance of male hormones (in this case abundance of testosterone). Spectrum of clinical symptoms include menstrual disorders, amenorrhoea, different range of hirsutism and virilization. Statistically, most androgen secreting tumors are ovarian aetiology (testosterone secreting tumors located in suprarenal gland are very rare). This rare tumor may produce excess amounts of testosterone, as well as its precursor androstenedione. The highest incidence is between 20-40 years and in postmenopausal period. The treatment is essentially surgical; with gradual adjustment of the hormones.

Keywords: androgen secreting ovarian tumors; hyperandrogenic states; testosterone; virilisation

Received: April 16, 2017; Accepted: January 2, 2018; Published: April 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mokáň M, Nehaj F, Sokol J, Vaňuga P, Mokáň M. Virilization as demonstration of hypertestosteronism by ovarian tumor: case report. Vnitr Lek. 2018;64(4):437-440. doi: 10.36290/vnl.2018.062.
Download citation

References

  1. Markopoulos MC, Kassi E, Alexandraki KI et al. Hyperandrogenism after menopause. Eur J Endocrinol 2015; 172(2): R79-R91. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-14-0468>. Go to original source... Go to PubMed...
  2. Stárka L, Dušková M. Androgeny a alopecie. DMEV 2005; 8(2): 75-78.
  3. Stárka L. Syndromy necitlivosti na androgeny. DMEV 1999; 2(3): 128-132.
  4. Dumic M, Simunic V, Ilic-Forko J et al. Extraovarian steroid cell tumor "not otherwise specified" as a rare cause of virilization in twelwe-year-old girl. DMEV 2000; 3(3): 210-211.
  5. Rittmaster RS. Hirsutism. Lancet 1997; 349(9046): 191-195. Dostupné z DOI: <http://dx.doi.org/10.1016/S0140-6736(96)07252-2>. Go to original source... Go to PubMed...
  6. Lazúrová I, Figurová J, Lazúrová Z. Diagnostika polycystických ovárií. Vnitř Lék 2015; 61(12 Suppl 5): 5S40-5S44.
  7. Vrbíková J. Vrozená adrenální hyperplazie v dospělosti. Vnitř Lék 2016; 62(9 Suppl 3): 3S131-3S134.
  8. Unluhizarci K, Kaltsas G, Kelestimur F. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Invest 2012; 42(1): 86-94. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2362.2011.02550.x>. Go to original source... Go to PubMed...
  9. Rothman MS, Wierman ME. How should postmenopausal androgenexcess be evaluated? Clin Endocrinol 2011; 75(2): 160-164. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2265.2011.04040.x>. Go to original source... Go to PubMed...
  10. Markopoulos MC, Rizos D, Valsamakis G et al. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. J Clin Endocrinol Metab 2011; 96(3): 623-631. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2010-0130>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.